|
Volumn 45, Issue 1-3, 2001, Pages 109-117
|
Monotherapy trials: Endpoints
|
Author keywords
Antiepileptic drugs; Endpoints; Monotherapy trials; Outcome measures
|
Indexed keywords
ANTICONVULSIVE AGENT;
CARBAMAZEPINE;
PHENOBARBITAL;
PHENYTOIN;
PLACEBO;
PRIMIDONE;
VALPROIC ACID;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE SEVERITY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG SCREENING;
DRUG TOLERABILITY;
EPILEPSY;
HUMAN;
INCIDENCE;
LIFE TABLE;
MONOTHERAPY;
NEUROTOXICITY;
OUTCOMES RESEARCH;
PHARMACOKINETICS;
PREVALENCE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RASH;
REMISSION;
SEIZURE;
TREATMENT OUTCOME;
ANTICONVULSANTS;
CLINICAL TRIALS;
ENDPOINT DETERMINATION;
EPILEPSY;
HUMANS;
LIFE TABLES;
RESEARCH DESIGN;
|
EID: 0034919320
PISSN: 09201211
EISSN: None
Source Type: Journal
DOI: 10.1016/S0920-1211(01)00232-7 Document Type: Conference Paper |
Times cited : (11)
|
References (24)
|